UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design

Human psychopharmacology, 2022-05, Vol.37 (3), p.e2826-n/a

2022

Volltextzugriff (PDF)

A New Paradigm to Indicate Antidepressant Treatments

Pharmaceuticals (Basel, Switzerland), 2021-12, Vol.14 (12), p.1288

2021

Volltextzugriff (PDF)

Microsampling Techniques Suitable for Therapeutic Drug Monitoring of Antipsychotics

Journal of clinical psychopharmacology, 2024-05, Vol.44 (3), p.302

2024

Volltextzugriff (PDF)

Validation of a method for the determination of Aderamastat (FP-025) in K2EDTA human plasma by LC-MS/MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-09, Vol.1245, p.124244, Article 124244

2024

Volltextzugriff (PDF)

The pharmacokinetics of antibiotics in cystic fibrosis

Expert opinion on drug metabolism & toxicology, 2021-01, Vol.17 (1), p.53-68

2021

Volltextzugriff (PDF)

Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels

Clinical pharmacokinetics, 2022-11, Vol.61 (11), p.1559-1569

2022

Volltextzugriff (PDF)

A multidisciplinary approach to forensic biological profiling on a single tooth and nail sample

International journal of legal medicine, 2024-10

2024

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Aminoglycosides in Neonates

Clinical pharmacokinetics, 2009-01, Vol.48 (2), p.71-88

2009

Volltextzugriff (PDF)

The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin

Research and practice in thrombosis and haemostasis, 2023-05, Vol.7 (4), p.100185-100185, Article 100185

2023

Volltextzugriff (PDF)

Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation

Therapeutic drug monitoring, 2011-04, Vol.33 (2), p.133-146

2011

Volltextzugriff (PDF)

An acute oral intoxication with haloperidol decanoate

The American journal of emergency medicine, 2017-09, Vol.35 (9), p.1387.e1-1387.e2

2017

Volltextzugriff (PDF)

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole

ERJ open research, 2023-05, Vol.9 (3), p.55

2023

Volltextzugriff (PDF)

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

Clinical pharmacokinetics, 2019-06, Vol.58 (6), p.747-766

2019

Volltextzugriff (PDF)

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy

Clinical pharmacology and therapeutics, 2024-08

2024

Volltextzugriff (PDF)

Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation

Therapeutic drug monitoring, 2012-10, Vol.34 (5), p.526-534

2012

Volltextzugriff (PDF)

Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study

Therapeutic drug monitoring, 2016-06, Vol.38 (3), p.402-406

2016

Volltextzugriff (PDF)

Does Circadian Rhythm Affect the Pharmacokinetics of Once-Daily Tobramycin in Adults With Cystic Fibrosis?

Therapeutic drug monitoring, 2020-08, Vol.42 (4), p.595-599

2020

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB

Journal of antimicrobial chemotherapy, 2016-10, Vol.71 (10), p.2691-2703

2016

Volltextzugriff (PDF)

An interlaboratory quality control programme for the measurement of tuberculosis drugs

The European respiratory journal, 2015-07, Vol.46 (1), p.268-271

2015

Volltextzugriff (PDF)

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

Therapeutic drug monitoring, 2019-02, Vol.41 (1), p.59-65

2019

Volltextzugriff (PDF)

Evaluation of Target Attainment for Tobramycin in Children and Adults with Cystic Fibrosis

Journal of clinical medicine, 2024-05, Vol.13 (9), p.2641

2024

Volltextzugriff (PDF)

Safety and pharmacokinetics of intravenous levetiracetam infusion as add‐on in status epilepticus

Epilepsia (Copenhagen), 2009-03, Vol.50 (3), p.415-421

2009

Volltextzugriff (PDF)

Optimization of anti-infective dosing regimens during online haemodiafiltration

Clinical kidney journal, 2017-04, Vol.10 (2), p.282-290

2017

Volltextzugriff (PDF)

Validation of a method for the determination of Aderamastat (FP-025) in K 2 EDTA human plasma by LC-MS/MS

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2024-09, Vol.1245, p.124244

2024

Volltextzugriff (PDF)

Azithromycin maintenance therapy in patients with cystic fibrosis: A dose advice based on a review of pharmacokinetics, efficacy, and side effects

Pediatric pulmonology, 2012-07, Vol.47 (7), p.658-665

2012

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(52)
Buchkapitel
(1)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(39)
Science & Technology
(39)
Humans
(27)
Pharmacology & Pharmacy
(20)
Pharmacokinetics
(15)
Female
(11)
Male
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Pharmacology. Drug Treatments
(10)
Toxicology
(8)
Anti-Bacterial Agents - Administration & Dosage
(7)
Anti-Bacterial Agents - Pharmacokinetics
(7)
Medical Laboratory Technology
(7)
Adult
(6)
Antibiotics
(6)
Pharmacology/toxicology
(6)
Middle Aged
(5)
Pharmacotherapy
(5)
Reproducibility Of Results
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design

A New Paradigm to Indicate Antidepressant Treatments

Microsampling Techniques Suitable for Therapeutic Drug Monitoring of Antipsychotics

Validation of a method for the determination of Aderamastat (FP-025) in K2EDTA human plasma by LC-MS/MS

The pharmacokinetics of antibiotics in cystic fibrosis

Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels

A multidisciplinary approach to forensic biological profiling on a single tooth and nail sample

Therapeutic Drug Monitoring of Aminoglycosides in Neonates

The right time to measure anti-Xa activity in critical illness: pharmacokinetics of therapeutic dose nadroparin

Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation

An acute oral intoxication with haloperidol decanoate

Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy

Influence of erroneous patient records on population pharmacokinetic modeling and individual bayesian estimation

Extended-Interval Dosing of Gentamicin Aiming for a Drug-Free Period in Neonates: A Prospective Cohort Study

Does Circadian Rhythm Affect the Pharmacokinetics of Once-Daily Tobramycin in Adults With Cystic Fibrosis?

Pharmacokinetic/pharmacodynamic-based optimization of levofloxacin administration in the treatment of MDR-TB

An interlaboratory quality control programme for the measurement of tuberculosis drugs

Darunavir Population Pharmacokinetic Model Based on HIV Outpatient Data

Evaluation of Target Attainment for Tobramycin in Children and Adults with Cystic Fibrosis

Safety and pharmacokinetics of intravenous levetiracetam infusion as add‐on in status epilepticus

Optimization of anti-infective dosing regimens during online haemodiafiltration

Validation of a method for the determination of Aderamastat (FP-025) in K 2 EDTA human plasma by LC-MS/MS

Azithromycin maintenance therapy in patients with cystic fibrosis: A dose advice based on a review of pharmacokinetics, efficacy, and side effects

Suchergebnisse filtern